Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tetomilast in Chronic Obstructive Pulmonary Disease (COPD)
NCT00917150Phase 2Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Mar 2009
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of tetomilast in chronic obstructive pulmonary disease (COPD), sponsored by Otsuka Pharmaceutical Co., Ltd.. Started Mar 2009; status: completed.
02
Drugs
tetomilast
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00917150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00917150.